Pyrazolo[4,3-c]isoquinolines as potential inhibitors of NF-kappaB activation.
Mortier J, Frederick R, Ganeff C, Remouchamps C, Talaga P, Pochet L, Wouters J, Piette J, Dejardin E, Masereel B.
Mortier J, et al. Among authors: piette j.
Biochem Pharmacol. 2010 May 15;79(10):1462-72. doi: 10.1016/j.bcp.2010.01.007. Epub 2010 Jan 21.
Biochem Pharmacol. 2010.
PMID: 20096267